Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,091.73%
#4 Black Phoenix Black Phoenix +335.34%
#5 aPriori aPriori +115.80%
#6 Bedrock Bedrock +73.38%
#7 Cysic Cysic +44.55%
#8 Prom Prom +41.94%
#9 COTI COTI +35.38%
#10 Playnance Playnance +34.37%
Coin of the day
Wrapped One Wrapped One
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Rang in Aktien #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Aktienkurs
$0.00023723
Zuletzt synchronisiert: 2024-08-26
Marktkapitalisierung
$1.41K
Veränderung (1 Tag)
111.67%
Veränderung (1 Jahr)
0.00%
Land
FR
Handel Pharnext S.A. (ALPHA)

Kategorie

Healthcare
EPS für Pharnext S.A. (ALPHA)
EPS zum December 2023 TTM: $-77.35M
Laut den aktuellen Finanzberichten und dem Aktienkurs von Pharnext S.A. beträgt das aktuelle EPS des Unternehmens (TTM) $-77.35M. Am Ende des Jahres 2022 betrug das EPS $-11.16K ein Rückgang im Vergleich zu dem EPS von 2021, das $-11.45K betrug.
EPS-Verlauf von Pharnext S.A. von 2013 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $-77.35M 35,598,509.46%
2023 $-217.28 -98.05%
2022 $-11.16K -2.49%
2021 $-11.45K 69.15%
2020 $-6.77K -21.06%
2019 $-8.57K -15.43%
2018 $-10.14K -100.00%
2017 $-6.00Qa 14.04%
2016 $-5.26Qa 44,068,612,420.18%
2015 $-11.94M -8.06%
2014 $-12.98M 1.29%
2013 $-12.82M 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -100.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -100.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -100.00%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR